Shorter product lifecycles, shrinking peak sales and heightened regulatory pressures have rendered the traditional life sciences supply chain an unaffordable luxury. As companies increasingly turn to unfamiliar emerging markets, a streamlined supply chain that can adapt to local regulations, cultural preferences and patient needs will be critical. Organizations must be able to deliver the right products to the right customers in a way that is efficient and generates returns quickly.
Value chain transformation can help life sciences companies achieve greater speed, efficiency and product certainty in today’s volatile market. Accenture maps out a blueprint for success.